Amazon has launched a new weight management program through Amazon One Medical that integrates primary care, pharmacy services and virtual care to support patients using GLP-1 medications.
The program, announced April 21 in a news release, aims to streamline obesity treatment by combining clinical care with medication access and delivery on a single platform.
The GLP-1 Management Program embeds weight loss treatment into a patient’s primary care relationship, allowing clinicians to monitor related conditions such as cardiovascular disease and diabetes while providing ongoing follow-up and treatment adjustments.
Amazon is also expanding access to GLP-1 medications through Amazon Pharmacy, offering oral and injectable options with upfront pricing. Costs start as low as $25 per month with insurance or $149 per month for oral medications and $299 per month for injectables for cash-paying patients, the release said.
Same-day delivery is available in nearly 3,000 cities and is expected to expand to about 4,500 by the end of 2026.
The company is also offering 24/7 telehealth prescription renewals for existing GLP-1 users, starting at $29 for messaging consultations.
Amazon said the program is designed to reduce fragmented care by connecting primary care, pharmacy and virtual services into a single experience for patients managing obesity.
